OOIR: Observatory of International Research

Papers

(The H4-Index of Brain is 66. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Complex genetic variants and novel phenotypes in hereditary peripheral neuropathies	287
Erratum to: Cardiovascular brain impulses in Alzheimer’s disease	276
Clinical dimensions along the non-fluent variant primary progressive aphasia spectrum	273
Recurrent de novo mutations in CLDN5 induce an anion-selective blood–brain barrier and alternating hemiplegia	264
Peripherin is a biomarker of axonal damage in Guillain-Barré syndrome: a pathophysiological annotation	222
A new Essay competition for Brain	182
Corrigendum to: Defective phosphatidylethanolamine biosynthesis leads to a broad ataxia-spasticity spectrum	181
Reply: Is postural tachycardia syndrome a psychogenic disorder?; Notes on establishing fear conditioning as causal in the postural orthostatic tachycardia syndrome; Patients with POTS fear that data o	163
Trigeminal nerve microstructure is linked with neuroinflammation and brainstem activity in migraine	155
Distinct roles of mTORC2 in excitatory and inhibitory neurons in inflammatory and neuropathic pain	153
Associations between accelerated forgetting, amyloid deposition and brain atrophy in older adults	134
Corrigendum to: CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer’s disease	134
Erratum to: Reply: UQCRC1 variants in Parkinson’s disease: a large cohort study in Chinese mainland population	129
Le Bal des Folles	127
Translating genetic and functional data into clinical practice: a series of 223 families with myotonia	126
c-Abl phosphorylation primes PARIS for neurodegeneration	125
MerTK is a mediator of alpha-synuclein fibril uptake by human microglia	121
Connecting dementia risk loci to the CSF proteome identifies pathophysiological leads for dementia	115
Brain repair mechanisms after cell therapy for stroke	114
Grey matter ageing-related tau astrogliopathy: associations with brain pathologies and cognitive decline	113
Store-operated calcium entry is reduced in spastin-linked hereditary spastic paraplegia	112
Post-acute blood biomarkers and disease progression in traumatic brain injury	111
Recovered grasping performance after stroke depends on interhemispheric frontoparietal connectivity	110
Structural (dys)connectivity associates with cholinergic cell density in Alzheimer’s disease	107
Mutation in senataxin alters the mechanism of R-loop resolution in amyotrophic lateral sclerosis 4	106

Gene variant effects across sodium channelopathies predict function and guide precision therapy	106
Proposed research criteria for prodromal behavioural variant frontotemporal dementia	105
Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson’s disease	102
Reply: Arcuate fasciculus’ middle and ventral temporal connections undercut by tract-tracing evidence	101
Corrigendum to: Comparative connectivity correlates of dystonic and essential tremor deep brain stimulation	100
Reply: A call for caution: ‘stop that’ sentiments threaten tic research, healthcare and advocacy progress	97
Shared patterns of glial transcriptional dysregulation link Huntington’s disease and schizophrenia	95
Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline	95
TwoRFC1splicing variants in CANVAS	94
Novel gene–intergenic fusion involving ubiquitin E3 ligase UBE3C causes distal hereditary motor neuropathy	93
Peripheral tau as a biomarker for neurodegenerative diseases: is life on Earth, life on Mars?	92
Inflammatory brain injury after severe viral infection is not unique to COVID-19	90
Proust and his neurologists: the challenge of functional disorders	90
Navigating the recurrent perplexity of prefrontal function	88
Reducing the risks of nuclear war: the role of health professionals	88
Is clinical assessment enough? Moving towards early differentiation of neurodegenerative parkinsonisms	88
Correction to: Variants in the SK2 channel gene (KCNN2) lead to dominant neurodevelopmental movement disorders	86
Sleep and longitudinal cognitive performance in preclinical and early symptomatic Alzheimer’s disease	85
Predicting behavioural outcomes after stroke: from computational challenge towards individualized rehabilitation?	85
3T MRI of rapid brain activity changes driven by subcallosal cingulate deep brain stimulation	83
From a different angle: 50 years of cerebral computed tomography	82
Beyond crystal balls: multimodal prediction of early recovery of consciousness	82
Droplet digital PCR as a first-tier molecular diagnostic tool for focal cortical dysplasia type II	82
Notes on establishing fear conditioning as causal in the postural orthostatic tachycardia syndrome	79
Corrigendum to: Monitoring the progression of Alzheimer's disease with τ-PET	79
Blocking an epitope of misfolded SOD1 ameliorates disease phenotype in a model of amyotrophic lateral sclerosis	78
Predictive precision medicine efforts for voltage-gated sodium channel genetic variants	78
Molecular pathology and biomarker of progression in Alzheimer’s disease	77
Ataxia with giant axonopathy in Acbd5-deficient mice halted by adeno-associated virus gene therapy	76
Lesions to both somatic and affective pain pathways lead to decreased salience network connectivity	76
Sleep and future cognitive decline	76
Prolonged myelin deficits contribute to neuron loss and functional impairments after ischaemic stroke	74
The impact of integrated brain molecular PET measures on DLB cognitive phenotype and clinical course	73
COP27 Climate Change Conference: urgent action needed for Africa and the world	71
Sex differences in Alzheimer’s disease risk: are immune responses the key?	71
Memantine: a novel treatment for children with developmental and epileptic encephalopathies	71
Clinical and genetic spectra of 1550 index patients with hereditary spastic paraplegia	70
Somatic variants of MAP3K3 are sufficient to cause cerebral and spinal cord cavernous malformations	68
Towards in vivo PET imaging of primary age-related tauopathy	68
Transthyretin attenuates TDP-43 proteinopathy by autophagy activation via ATF4 in FTLD-TDP	67
Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development	66
Correction to: Cytotoxic T cells and plasma cells dominate early in temporal lobe epilepsy with GAD antibodies	66
Targeting enkephalins and pituitary adenylate cyclase-activating polypeptide (PACAP) in migraine	66